COMMUNIQUÉS West-GlobeNewswire

Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration
29/07/2025
Data readout expected in Q1 2026 MIAMI, July 29, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced that it has completed subject enrollment in [...]
UroGen Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 7th, 2025
29/07/2025
Conference Call and Webcast Scheduled for Thursday, August 7 th , 2025, at 10:00 AM ET PRINCETON, N.J., July 29, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and [...]
Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer
29/07/2025
SYDNEY, AUSTRALIA, July 29, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces an [...]
Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream
29/07/2025
A first-of-its-kind solution for women’s arousal in a proprietary topical formulation demonstrated to work where women need it most Targeted to be available by prescription in the fourth quarter of 2025 Collaboration [...]
ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement
29/07/2025
Proxy Sets Company on a Path to Attract the Optimal Crypto Treasury Strategy Increase in Authorized Shares to 1 Billion Would Position the Company to Attract Industry-Leading Market Participants and High-Value Crypto [...]
Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease
29/07/2025
- Pioneering approach to halting the chronic neuroinflammation responsible for neurodegeneration - Trial to assess safety, PK and detect early signs of efficacy - Initial data expected in mid-2026 SACRAMENTO, Calif., [...]
Branded Legacy, Inc. Signs Letter of Intent to Acquire Bio-Legacy Evaluative Group, Advancing Innovations in Intranasal Drug Delivery
29/07/2025
Strategic Acquisition Positions Branded Legacy to Enter the Growing Naloxone and Vaccine Markets, Enhancing Shareholder Value; Leadership Transition Planned with Amin Janmohamed as New CEO and Chairman MELBOURNE, Fla., [...]
Cedar Gate Data Finds Nearly 60% of New Mothers Miss Essential Postpartum Follow-Up Care
29/07/2025
Nationwide analysis of commercially insured members shows missed appointments far exceed prior estimates, highlighting urgent gaps in maternal health access GREENWICH, Conn., July 29, 2025 (GLOBE NEWSWIRE) -- Cedar Gate [...]
IMUNON to Hold Second Quarter 2025 Financial Results and Business Update Conference Call on Tuesday, August 5, 2025
29/07/2025
LAWRENCEVILLE, N.J., July 29, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (NASDAQ: IMNN) , a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, announces that the Company will host a [...]
Foundation Health to Bring AI-Powered Patient Communication to Intermountain Health’s Specialty Pharmacy Patients
29/07/2025
Foundation Health’s PAIGE AI Will Streamline Operations and Enhance Care Experience for Intermountain Health’s 14,000 Specialty Pharmacy Patients SAN FRANCISCO, July 29, 2025 (GLOBE NEWSWIRE) -- In a new strategic [...]
Quoin Pharmaceuticals Provides Product Portfolio Update
29/07/2025
Lead Product, QRX003, Being Tested in Two Active Registrational Clinical Studies for Netherton Syndrome Across the U.S., Europe, and the Middle East. QRX003 Peeling Skin Syndrome Clinical Program Continues Following [...]
Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference
29/07/2025
SEATTLE and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and [...]
CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference
29/07/2025
MINNEAPOLIS, July 29, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
The International Myeloma Foundation Mourns the Loss of Accomplished Attorney and Longtime Board Member Benson Klein
29/07/2025
STUDIO CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announces with great sadness the passing of our beloved and longtime Board Member Benson Klein, JD. After living [...]
Cannabix Technologies Receives Notice of Allowance from CIPO for Contactless Breath Analysis Patent Application
29/07/2025
VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the Canadian Intellectual [...]
New Imprivata Report: Hospitals Save an Average of $1.1M Annually with Shared Mobile Devices, But Most Still Lack a Formal Use Policy
29/07/2025
Shared mobile devices deliver significant benefits to clinical workflows and patient care, but gaps in user experience, oversight, and policy enforcement still limit their full impact WALTHAM, Mass., July 29, 2025 ( [...]
Concept Life Sciences & Fios Genomics Partner to Enhance Complex Data Analysis in Drug Discovery
29/07/2025
Strategic alliance based in the Edinburgh BioQuarter provides clients with richer data analysis, driving smarter, data-driven decisions CHAPEL-EN-LE-FRITH and EDINBURGH, United Kingdom, July 29, 2025 (GLOBE NEWSWIRE [...]
Meliodays and Celanese Partner for Meliodays’ Development of Hormone-Free Non-Contraceptive IUD designed to Treat Menstrual Pain
29/07/2025
Celanese’s VitalDose ® Drug Delivery Platform will enable a long-acting, patient-centric formulation for Meliodays’ IUD design MUNICH, July 29, 2025 (GLOBE NEWSWIRE) -- Meliodays Medical and Celanese Corporation (NYSE: [...]
Philips builds strong order intake momentum and drives margin expansion in Q2
29/07/2025
July 29, 2025 Q2 2025 Group Highlights Comparable order intake growth 6% Group sales EUR 4.3 billion, reflecting 1% increase in comparable sales Income from operations EUR 400 million Adjusted EBITA margin increased 130 [...]

Pages